Reversal of Battle-Related Aging (ROBRA) in a Special Operations Forces Cohort
NCT05855876 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2023-07-17
Summary
The purpose of this study is to examine measures of GrimAge clock in SOF members undergoing treatment for PTSD/TBI using CSB.
Conditions
- Post-Traumatic Stress Disorder
- Traumatic Brain Injury
Interventions
- PROCEDURE
-
subanesthetic ketamine infusions and bilateral cervical sympathetic blocks
Combined protocol of subanesthetic ketamine infusions and bilateral cervical sympathetic blocks
Sponsors & Collaborators
-
Stella Center
lead OTHER
Principal Investigators
-
Eugene Lipov, MD · Stella Center
Eligibility
- Min Age
- 40 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-05
- Primary Completion
- 2024-04-05
- Completion
- 2024-04-05
Countries
- United States
Study Locations
More Related Trials
-
Amantadine Therapy for Cognitive Impairment in Long COVID
NCT06055244 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents
NCT06957704 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Clinical Trial of De-stress and Focus Capsule in the Management of Stress.
NCT06569849 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.
NCT00495729 ·Status: COMPLETED ·Phase: PHASE1
-
Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression
NCT06317636 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
NCT03642028 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia
NCT06644573 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability
NCT00368056 ·Status: COMPLETED ·Phase: PHASE3
-
Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia
NCT05289518 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess the Wakefulness Promoting Effect, Safety, Tolerability, and Pharmacokinetics (PK) of LML134 in Shift Work Disorder
NCT03141086 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of LY3154207 on Sleep in Healthy Male Participants
NCT02603861 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of De-Stress & Snooze Gummies in Reducing Stress and Insomnia Disorder
NCT06571331 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II
NCT06867549 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Sleeping Without Pills (SWOP), an Online Drug Tapering Program
NCT03194802 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)
NCT06525077 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Rozerem on Sleep Among People With Traumatic Brain Injury
NCT01207050 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Suvorexant on Sympathetic Nerve Activity and Baroreflex Function in Chronic Insomnia
NCT03768713 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury
NCT00983437 ·Status: TERMINATED ·Phase: PHASE3
-
Use of Blinded Tapering for Hypnotic Discontinuation
NCT04050176 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD
NCT03062540 ·Status: TERMINATED ·Phase: PHASE3
-
Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
NCT04789174 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Suvorexant for Reduction of Brain Reactivity in Patients With Cannabis Use Disorder (Pilot Study)
NCT06584942 ·Status: RECRUITING ·Phase: PHASE4
-
Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL
NCT00236080 ·Status: COMPLETED ·Phase: PHASE3
-
An Exploratory Study of NBI-34060 Capsules and Next Day Functioning
NCT00525941 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Sleep-Oriented Intervention for Suicidal Behaviors
NCT01770587 ·Status: COMPLETED ·Phase: NA